Evidence map›Paper›PMID 19681600›Full record

ArticleBiochemistry2009

Effect of thioredoxin deletion and p53 cysteine replacement on human p53 activity in wild-type and thioredoxin reductase null yeast.

Christopher S Stoner, George D Pearson, Ahmet Koç, Jason R Merwin, Nathan I Lopez, Gary F Merrill

Open access · greenAbstract read
In one paragraph

Article in Biochemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. The cysteine proteome.Free radical biology & medicine · 2015
    Review
  5. Review
  6. p53, aerobic metabolism, and cancer.Antioxidants & redox signaling · 2011
    Review
  7. Article
  8. Article
  9. Stabilization of mutant p53 via alkylation of cysteines and effects on DNA binding.Protein science : a publication of the Protein Society · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Christopher S StonerDepartment of Biochemistry and Biophysics, Oregon State University, 2011 ALS Building, Corvallis, Oregon 97331-7305, USA.
George D Pearson
Ahmet Koç
Jason R Merwin
Nathan I Lopez
Gary F Merrill
Oregon State University · US

Funding

Reducing Susceptibility to Environmental Stress Throughout the Life SpanP30ES000210 · NIEHS · OREGON STATE UNIVERSITY · PI BECKMAN, JOSEPH S · 1985 to 2015
$21.4M
DEPENDENCE OF P53 ON THIOL MAINTENANCE PROTEINSR01CA082633 · NCI · OREGON STATE UNIVERSITY · PI MERRILL, GARY F · 1999 to 2001
$268k
NCI NIH HHS R01 CA082633NCI NIH HHS R01 CA82633NIEHS NIH HHS P30 ES000210NIEHS NIH HHS P30 ES00210
6 · The paper itself

Abstract

Reporter gene transactivation by human p53 is inhibited in budding yeast lacking the TRR1 gene encoding thioredoxin reductase. To investigate the role of thioredoxin in controlling p53 activity, the level of reporter gene transactivation by p53 was determined in yeast lacking the TRX1 and TRX2 genes encoding cytosolic thioredoxin. Surprisingly, p53 activity was unimpaired in yeast lacking thioredoxin. Subsequent analyses showed that thioredoxin deletion suppressed the inhibitory effect of thioredoxin reductase deletion, suggesting that accumulation of oxidized thioredoxin in mutant yeast was necessary for p53 inhibition. Purified human thioredoxin and p53 interacted in vitro (Kd = 0.9 microM thioredoxin). To test the idea that dithio-disulfide exchange reactions between p53 and thioredoxin were responsible for p53 inhibition in mutant yeast, each p53 cysteine was changed to serine, and the effect of the substitution on p53 activity in TRR1 and Deltatrr1 yeast was determined. Substitutions at Zn-coordinating cysteines C176, C238, or C242 resulted in p53 inactivation. Unexpectedly, substitution at cysteine C275 also inactivated p53, which was the first evidence for a non-zinc-coordinating cysteine being essential for p53 function. Cysteine substitutions at six positions (C124, C135, C141, C182, C229, and C277) neither inactivated p53 nor relieved the requirement for thioredoxin reductase. Furthermore, no tested combination of these six cysteine substitutions relieved thioredoxin reductase dependence. The results suggested that p53 dependence on thioredoxin reductase either was indirect, perhaps mediated by an upstream activator of p53, or was due to oxidation of one or more of the four essential cysteines.

Indexed as

Amino Acid SubstitutionBase SequenceCell LineCysteineDNA PrimersGene DeletionGenes, FungalGenes, ReporterGenetic Complementation TestHumansIn Vitro TechniquesKineticsMutagenesis, Site-DirectedOxidation-ReductionRecombinant ProteinsSaccharomyces cerevisiaeCysteineDNA PrimersRecombinant ProteinsThioredoxin-Disulfide ReductaseThioredoxinsTP53 protein, humanTumor Suppressor Protein p53

Identifiers

PMID19681600
PMCPMC2785850
OpenAlexW1994668567

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.